Repertoire Immune Medicines
From immune codes to immune medicines.
Cambridge, United States · Founded 2020 · $289.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2020
- Business Model
- B2B
- Website
- repertoire.com
- Total Funding
- $289.0M
- Last Round
- $35.0M Venture RoundApr 2025
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.
About
Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to treat cancer and autoimmune diseases. Founded in 2020 and headquartered in Cambridge, Massachusetts (with additional operations in Zurich, Switzerland), Repertoire was founded under Flagship Pioneering. The company's proprietary DECODE platform provides comprehensive insights into the immune synapse — the central hardware of the adaptive immune system — identifying T cell receptor (TCR) and antigen epitope pairs across all human HLAs. Using these discovered 'immune codes,' Repertoire designs TCR bispecific molecules, mRNA cancer vaccines, and mRNA tolerizing vaccines to program the immune system to eliminate tumors and restore immune balance in autoimmune patients. The company has established collaborations with Eli Lilly, Genentech, and Pfizer, and is advancing a pipeline of candidates in immuno-oncology and autoimmune disease indications.
Summary
Repertoire Immune Medicines is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $289.0M in total across 4 rounds, most recently a $35.0M Venture Round in Apr 2025. Investors include Flagship Pioneering, Roche and SoftBank.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2025
Sign up to see all 4 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/repertoire-immune-medicines"><img src="https://indexed.vc/api/badge/company/repertoire-immune-medicines" alt="Repertoire Immune Medicines on Indexed.vc" width="260" height="76" /></a>


